Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Ronald L. Thibert, D.O.

Concepts

This page shows the publications Ronald Thibert has written about Treatment Outcome.
Connection Strength

0.187
  1. The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome. Neurology. 2021 02 16; 96(7):e1024-e1035.
    View in: PubMed
    Score: 0.035
  2. Diazepam for outpatient treatment of nonconvulsive status epilepticus in pediatric patients with Angelman syndrome. Epilepsy Behav. 2018 05; 82:74-80.
    View in: PubMed
    Score: 0.029
  3. Low glycemic index treatment for seizure control in Angelman syndrome: A case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital. Epilepsy Behav. 2017 03; 68:45-50.
    View in: PubMed
    Score: 0.026
  4. Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital. Epilepsy Behav. 2016 07; 60:138-141.
    View in: PubMed
    Score: 0.025
  5. A survey of seizures and current treatments in 15q duplication syndrome. Epilepsia. 2014 Mar; 55(3):396-402.
    View in: PubMed
    Score: 0.022
  6. Low glycemic index treatment for seizures in Angelman syndrome. Epilepsia. 2012 Sep; 53(9):1498-502.
    View in: PubMed
    Score: 0.019
  7. Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options. Epilepsia. 2009 Nov; 50(11):2369-76.
    View in: PubMed
    Score: 0.016
  8. Reversible uncal herniation in a neonate with a large MCA infarct. Brain Dev. 2009 Nov; 31(10):763-5.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.